183 related articles for article (PubMed ID: 34145365)
1. Loss of histone methyltransferase ASH1L in the developing mouse brain causes autistic-like behaviors.
Gao Y; Duque-Wilckens N; Aljazi MB; Wu Y; Moeser AJ; Mias GI; Robison AJ; He J
Commun Biol; 2021 Jun; 4(1):756. PubMed ID: 34145365
[TBL] [Abstract][Full Text] [Related]
2. Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model.
Gao Y; Aljazi MB; Wu Y; He J
Neurosci Lett; 2021 Nov; 764():136241. PubMed ID: 34509565
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of autism risk factor ASH1L in prefrontal cortex induces epigenetic aberrations and seizures.
Qin L; Williams JB; Tan T; Liu T; Cao Q; Ma K; Yan Z
Nat Commun; 2021 Nov; 12(1):6589. PubMed ID: 34782621
[TBL] [Abstract][Full Text] [Related]
4. ASH1L mutation caused seizures and intellectual disability in twin sisters.
Liu H; Liu DT; Lan S; Yang Y; Huang J; Huang J; Fang L
J Clin Neurosci; 2021 Sep; 91():69-74. PubMed ID: 34373061
[TBL] [Abstract][Full Text] [Related]
5. ASH1L haploinsufficiency results in autistic-like phenotypes in mice and links Eph receptor gene to autism spectrum disorder.
Yan Y; Tian M; Li M; Zhou G; Chen Q; Xu M; Hu Y; Luo W; Guo X; Zhang C; Xie H; Wu QF; Xiong W; Liu S; Guan JS
Neuron; 2022 Apr; 110(7):1156-1172.e9. PubMed ID: 35081333
[TBL] [Abstract][Full Text] [Related]
6. Neural Hyperactivity Is a Core Pathophysiological Change Induced by Deletion of a High Autism Risk Gene
Gao Y; Aljazi MB; He J
Front Behav Neurosci; 2022; 16():873466. PubMed ID: 35449559
[No Abstract] [Full Text] [Related]
7. Expansion of the Genotypic and Phenotypic Spectrum of
Cordova I; Blesson A; Savatt JM; Sveden A; Mahida S; Hazlett H; Rooney Riggs E; Chopra M;
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674358
[TBL] [Abstract][Full Text] [Related]
8. Novel MCA/ID syndrome with ASH1L mutation.
Okamoto N; Miya F; Tsunoda T; Kato M; Saitoh S; Yamasaki M; Kanemura Y; Kosaki K
Am J Med Genet A; 2017 Jun; 173(6):1644-1648. PubMed ID: 28394464
[TBL] [Abstract][Full Text] [Related]
9. Counteracting epigenetic mechanisms regulate the structural development of neuronal circuitry in human neurons.
Cheon S; Culver AM; Bagnell AM; Ritchie FD; Vacharasin JM; McCord MM; Papendorp CM; Chukwurah E; Smith AJ; Cowen MH; Moreland TA; Ghate PS; Davis SW; Liu JS; Lizarraga SB
Mol Psychiatry; 2022 Apr; 27(4):2291-2303. PubMed ID: 35210569
[TBL] [Abstract][Full Text] [Related]
10. Role of Ash1l in Tourette syndrome and other neurodevelopmental disorders.
Zhang C; Xu L; Zheng X; Liu S; Che F
Dev Neurobiol; 2021 Mar; 81(2):79-91. PubMed ID: 33258273
[TBL] [Abstract][Full Text] [Related]
11. Functional convergence of histone methyltransferases EHMT1 and KMT2C involved in intellectual disability and autism spectrum disorder.
Koemans TS; Kleefstra T; Chubak MC; Stone MH; Reijnders MRF; de Munnik S; Willemsen MH; Fenckova M; Stumpel CTRM; Bok LA; Sifuentes Saenz M; Byerly KA; Baughn LB; Stegmann APA; Pfundt R; Zhou H; van Bokhoven H; Schenck A; Kramer JM
PLoS Genet; 2017 Oct; 13(10):e1006864. PubMed ID: 29069077
[TBL] [Abstract][Full Text] [Related]
12. Mutations in ASH1L confer susceptibility to Tourette syndrome.
Liu S; Tian M; He F; Li J; Xie H; Liu W; Zhang Y; Zhang R; Yi M; Che F; Ma X; Zheng Y; Deng H; Wang G; Chen L; Sun X; Xu Y; Wang J; Zang Y; Han M; Wang X; Guan H; Ge Y; Wu C; Wang H; Liang H; Li H; Ran N; Yang Z; Huang H; Wei Y; Zheng X; Sun X; Feng X; Zheng L; Zhu T; Luo W; Chen Q; Yan Y; Huang Z; Jing Z; Guo Y; Zhang X; Schaaf CP; Xing J; Wang C; Yu F; Guan JS
Mol Psychiatry; 2020 Feb; 25(2):476-490. PubMed ID: 31673123
[TBL] [Abstract][Full Text] [Related]
13. Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma.
Xu B; Qin T; Yu J; Giordano TJ; Sartor MA; Koenig RJ
J Biol Chem; 2020 Jun; 295(26):8834-8845. PubMed ID: 32398261
[TBL] [Abstract][Full Text] [Related]
14. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.
Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY
J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787
[TBL] [Abstract][Full Text] [Related]
15. Increased rates of cerebral protein synthesis in Shank3 knockout mice: Implications for a link between synaptic protein deficit and dysregulated protein synthesis in autism spectrum disorder/intellectual disability.
Torossian A; Saré RM; Loutaev I; Smith CB
Neurobiol Dis; 2021 Jan; 148():105213. PubMed ID: 33276083
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy.
Lumish HS; Wynn J; Devinsky O; Chung WK
J Autism Dev Disord; 2015 Nov; 45(11):3764-70. PubMed ID: 26084711
[TBL] [Abstract][Full Text] [Related]
17. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
[TBL] [Abstract][Full Text] [Related]
18. Distinct Pathogenic Genes Causing Intellectual Disability and Autism Exhibit a Common Neuronal Network Hyperactivity Phenotype.
Frega M; Selten M; Mossink B; Keller JM; Linda K; Moerschen R; Qu J; Koerner P; Jansen S; Oudakker A; Kleefstra T; van Bokhoven H; Zhou H; Schubert D; Nadif Kasri N
Cell Rep; 2020 Jan; 30(1):173-186.e6. PubMed ID: 31914384
[TBL] [Abstract][Full Text] [Related]
19. Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype.
Kojic M; Gawda T; Gaik M; Begg A; Salerno-Kochan A; Kurniawan ND; Jones A; Drożdżyk K; Kościelniak A; Chramiec-Głąbik A; Hediyeh-Zadeh S; Kasherman M; Shim WJ; Sinniah E; Genovesi LA; Abrahamsen RK; Fenger CD; Madsen CG; Cohen JS; Fatemi A; Stark Z; Lunke S; Lee J; Hansen JK; Boxill MF; Keren B; Marey I; Saenz MS; Brown K; Alexander SA; Mureev S; Batzilla A; Davis MJ; Piper M; Bodén M; Burne THJ; Palpant NJ; Møller RS; Glatt S; Wainwright BJ
Nat Commun; 2021 May; 12(1):2678. PubMed ID: 33976153
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l.
Yin B; Yu F; Wang C; Li B; Liu M; Ye L
Stem Cells; 2019 Jan; 37(1):115-127. PubMed ID: 30270478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
